Cipla Europe NV tied up with Serum Institute of India to distribute vaccines in Europe

Nov 21, 2014 12:09 IST

Cipla Europe NV, a wholly-owned subsidiary of Cipla Ltd on 20 November 2014 tied up with Serum Institute of India Ltd (SII) to distribute vaccines in Europe.

Under the agreement, SII will develop and manufacture paediatric vaccines. On the other hand, Cipla will seek European Medicines Agency approval and market the products in Europe.

Serum Institute of India Ltd (SII)
Serum Institute of India was founded in 1966 with the aim of manufacturing life-saving immuno-biologicals, which were in shortage in the country and imported at high prices.

Today, Serum Institute of India Ltd is the World's largest producer of Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines.

Vaccines manufactured by the Serum Institute are accredited by the World Health Organization and are being used in around 140 countries across the globe in their national immunization programs.

Is this article important for exams ? Yes5 People Agreed
Read more Current Affairs on: Cipla , Serum Institute of India , vaccines , SII

Latest Videos

Register to get FREE updates

    All Fields Mandatory
  • (Ex:9123456789)
  • Please Select Your Interest
  • Please specify

  • ajax-loader
  • A verifcation code has been sent to
    your mobile number

    Please enter the verification code below

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK